First Bank & Trust Decreases Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

First Bank & Trust decreased its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 2.0% in the 1st quarter, HoldingsChannel.com reports. The fund owned 7,936 shares of the medical equipment provider’s stock after selling 159 shares during the quarter. First Bank & Trust’s holdings in Intuitive Surgical were worth $3,167,000 as of its most recent SEC filing.

Other large investors have also modified their holdings of the company. Dark Forest Capital Management LP grew its stake in Intuitive Surgical by 66.6% during the 3rd quarter. Dark Forest Capital Management LP now owns 1,306 shares of the medical equipment provider’s stock worth $382,000 after purchasing an additional 522 shares in the last quarter. Operose Advisors LLC acquired a new position in shares of Intuitive Surgical during the third quarter worth about $39,000. O Shaughnessy Asset Management LLC grew its position in shares of Intuitive Surgical by 33.2% during the third quarter. O Shaughnessy Asset Management LLC now owns 20,569 shares of the medical equipment provider’s stock worth $6,012,000 after buying an additional 5,132 shares in the last quarter. Mutual Advisors LLC increased its stake in shares of Intuitive Surgical by 27.9% during the third quarter. Mutual Advisors LLC now owns 834 shares of the medical equipment provider’s stock worth $244,000 after buying an additional 182 shares during the period. Finally, Bamco Inc. NY raised its holdings in Intuitive Surgical by 0.5% in the third quarter. Bamco Inc. NY now owns 168,401 shares of the medical equipment provider’s stock valued at $49,222,000 after acquiring an additional 840 shares in the last quarter. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Insiders Place Their Bets

In other Intuitive Surgical news, Director Alan J. Levy sold 2,000 shares of Intuitive Surgical stock in a transaction that occurred on Tuesday, April 23rd. The stock was sold at an average price of $370.70, for a total value of $741,400.00. Following the sale, the director now owns 25,319 shares of the company’s stock, valued at approximately $9,385,753.30. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. In other news, Director Craig H. Barratt sold 1,400 shares of the company’s stock in a transaction on Wednesday, June 12th. The shares were sold at an average price of $421.06, for a total transaction of $589,484.00. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, Director Alan J. Levy sold 2,000 shares of the firm’s stock in a transaction dated Tuesday, April 23rd. The shares were sold at an average price of $370.70, for a total transaction of $741,400.00. Following the completion of the sale, the director now owns 25,319 shares of the company’s stock, valued at approximately $9,385,753.30. The disclosure for this sale can be found here. In the last quarter, insiders sold 17,956 shares of company stock worth $6,927,011. 0.90% of the stock is owned by insiders.

Intuitive Surgical Stock Down 0.1 %

ISRG stock traded down $0.26 during trading on Friday, hitting $444.85. The company had a trading volume of 3,106,192 shares, compared to its average volume of 1,372,778. Intuitive Surgical, Inc. has a 1-year low of $254.85 and a 1-year high of $447.11. The firm has a 50-day moving average price of $403.83 and a 200-day moving average price of $383.12. The firm has a market cap of $157.79 billion, a PE ratio of 80.30, a price-to-earnings-growth ratio of 5.75 and a beta of 1.39.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings results on Thursday, April 18th. The medical equipment provider reported $1.50 EPS for the quarter, topping the consensus estimate of $1.40 by $0.10. Intuitive Surgical had a return on equity of 12.91% and a net margin of 27.16%. The business had revenue of $1.89 billion during the quarter, compared to analysts’ expectations of $1.87 billion. During the same quarter in the prior year, the business earned $1.00 earnings per share. The company’s quarterly revenue was up 11.5% compared to the same quarter last year. Sell-side analysts anticipate that Intuitive Surgical, Inc. will post 4.8 earnings per share for the current year.

Analyst Upgrades and Downgrades

A number of brokerages have commented on ISRG. Piper Sandler increased their price objective on shares of Intuitive Surgical from $425.00 to $435.00 and gave the company an “overweight” rating in a research report on Friday, April 19th. Citigroup increased their target price on Intuitive Surgical from $428.00 to $462.00 and gave the company a “buy” rating in a report on Wednesday, April 3rd. Stifel Nicolaus lifted their price target on Intuitive Surgical from $420.00 to $430.00 and gave the stock a “buy” rating in a report on Monday, April 8th. Robert W. Baird dropped their price objective on Intuitive Surgical from $440.00 to $436.00 and set an “outperform” rating on the stock in a report on Friday, April 19th. Finally, BTIG Research boosted their target price on Intuitive Surgical from $412.00 to $421.00 and gave the stock a “buy” rating in a research note on Friday, April 19th. Five analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $403.67.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.